Rapidly Evolving Pre- and Post-surgical Systemic Treatment of Melanoma

With the development of effective BRAF -targeted and immune-checkpoint immunotherapies for metastatic melanoma, clinical trials are moving these treatments into earlier adjuvant and perioperative settings. BRAF -targeted therapy is a standard of care in resected stage III–IV melanoma, while anti-pro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of clinical dermatology 2024-05, Vol.25 (3), p.421-434
Hauptverfasser:	Augustin, Ryan C., Luke, Jason J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Biomarkers, Tumor Dermatology Gene expression Humans Immune Checkpoint Inhibitors - therapeutic use Immunotherapy Medicine Medicine & Public Health Melanoma Melanoma - drug therapy Melanoma - pathology Melanoma - therapy Metastasis Neoadjuvant Therapy - methods Neoplasm Recurrence, Local - prevention & control Neoplasm Staging Patients Pharmacology/Toxicology Pharmacotherapy Proto-Oncogene Proteins B-raf - antagonists & inhibitors Proto-Oncogene Proteins B-raf - genetics Review Article Skin cancer Skin Neoplasms - drug therapy Skin Neoplasms - immunology Skin Neoplasms - pathology Skin Neoplasms - therapy Standard of care Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!